» Authors » Sonya Cunningham

Sonya Cunningham

Explore the profile of Sonya Cunningham including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 226
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalivendi S, Konorev E, Cunningham S, Vanamala S, Kaji E, Joseph J, et al.
Biochem J . 2005 Apr; 389(Pt 2):527-39. PMID: 15799720
Doxorubicin (DOX), a widely used antitumour drug, causes dose-dependent cardiotoxicity. Cardiac mitochondria represent a critical target organelle of toxicity during DOX chemotherapy. Proposed mechanisms include generation of ROS (reactive oxygen...
2.
Patel S, Carrier E, Vanessa Ho W, Rademacher D, Cunningham S, Reddy D, et al.
J Lipid Res . 2004 Dec; 46(2):342-9. PMID: 15576840
N-arachidonylethanolamine (AEA) accumulates during brain injury and postmortem. Because fatty acid amide hydrolase (FAAH) regulates brain AEA content, the purpose of this study was to determine its role in the...
3.
Kalivendi S, Cunningham S, Kotamraju S, Joseph J, Hillard C, Kalyanaraman B
J Biol Chem . 2004 Jan; 279(15):15240-7. PMID: 14742448
1-Methyl-4-phenylpyridinium (MPP(+)) is a neurotoxin that causes Parkinson's disease in experimental animals and humans. Despite the fact that intracellular iron was shown to be crucial for MPP(+)-induced apoptotic cell death,...
4.
Kalivendi S, Kotamraju S, Cunningham S, Shang T, Hillard C, Kalyanaraman B
Biochem J . 2003 Jan; 371(Pt 1):151-64. PMID: 12523938
1-Methyl-4-phenylpyridinium (MPP(+)) is a neurotoxin used in cellular models of Parkinson's Disease. Although intracellular iron plays a crucial role in MPP(+)-induced apoptosis, the molecular signalling mechanisms linking iron, reactive oxygen...